dSMAX-2

UBA1 | 2008

What Is dSMAX-2?

dSMAX-2 is a type of CMT caused by X-linked recessive mutations in the UBA1 gene. This gene provides instructions for making an enzyme that activates the tagging of proteins for regulated breakdown, essential to motor nerve cell function. Mutations in the UBA1 gene disrupt this function, leading to impaired nerve signal transmission.

dSMAX-2 is X-linked recessive. This means the gene lives on the X chromosome, and in people with two X chromosomes (chromosomal females), a mutation in both copies of the gene is needed to cause dSMAX-2. For individuals with one X and one Y chromosome (chromosomal males), a mutation in their single copy of the gene is sufficient to cause dSMAX-2.

Clinical Features

The age of symptom onset in dSMAX-2 is variable, ranging from childhood to adulthood. As a motor neuropathy, dSMAX-2 primarily affects the most distal points, with weakness and atrophy of the feet and hands, and little to no involvement of the sensory nerves. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dSMAX-2 symptoms may include:

  • Weakness and atrophy in the feet and lower legs
  • Foot drop
  • Reduced or absent reflexes
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dSMAX-2 shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dSMAX-2

Classification
dSMA

Neuropathy Type
Axonal

Inheritance Pattern
X-linked recessive

Genetic Context

HGNC-Approved Gene Symbol
UBA1

Gene Full Name
ubiquitin like modifier activating enzyme 1

HGNC Gene Alias(es)
GXP1, UBE1

Chromosome
Xp11.3

Zygosity of Responsible Variant
Hemizygous (Male)/Homozygous (Female)

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Hypomorphic

Confidence:
High

Prediction:
The literature predicts a loss-of-function mechanism for dSMAX-2: UBA1 encodes the sole E1 enzyme that activates ubiquitin and charges the downstream E2 cascade, and the hypomorphic exon 15 missense alleles (p.Met539Ile, p.Ser547Gly) together with expression-lowering regulatory variants leave residual activity too low to sustain protein turnover in motor neurons. Hemizygous males carry that reduced-function copy as their only UBA1, and restored wild-type E1 is predicted to rescue. Somatic p.Met41 variants confined to the myeloid lineage instead cause VEXAS syndrome, an acquired inflammatory disease.

Rationale:
A hemizygous male expresses no wild-type E1 for a mutant subunit to interfere with, so interference is unavailable as a mechanism and the phenotype tracks residual enzyme activity alone. Because ubiquitin activation is essential to every cell, only partial-function alleles are compatible with survival, and the motor neuron is where falling conjugation capacity shows first.

ClinVar Pathogenic Variants

View UBA1 ClinVar Variants

dSMAX-2 OMIM Entry

dSMAX-2 OMIM

UBA1 OMIM Entry

UBA1 OMIM

More Info

dSMAX-2 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Rare Missense and Synonymous Variants in UBE1 are Associated with X-Linked Infantile Spinal Muscular Atrophy

Authors

Ramser, J., Ahearn, M. E., Lenski, C., Yariz, K. O., Hellebrand, H., von Rhein, M., Clark, R. D., Schmutzler, R. K., Lichtner, P., Hoffman, E. P., Meindl, A., & Baumbach-Reardon, L.

Publication Date
January 10, 2008

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.